An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice

References

• Beeldman E, Raaphorst J, Twennaar MK, De Visser M, Schmand BA, De Haan RJ. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016;87:611–9.
   PubMed Web of Science ®Google Scholar
• Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
   PubMed Web of Science ®Google Scholar
• Burrell JR, Halliday GM, Kril JJ, Ittner LM, Götz J, Kiernan MC, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet 2016;388:919–31.
   PubMed Web of Science ®Google Scholar
• Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11:232–40.
   PubMed Web of Science ®Google Scholar
• Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263–9.
   PubMed Web of Science ®Google Scholar
• Khin Khin E, Minor D, Holloway A, Pelleg A. Decisional capacity in amyotrophic lateral sclerosis. J Am Acad Psychiatry Law. 2015;43:210–7.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Abrahams S, Goldstein LH, Woolley SC, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Front Degener. 2017;18:153–74.
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
   PubMed Web of Science ®Google Scholar
• Simon N, Goldstein LH. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Front Degener. 2019;20:1–11.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement (Reprinted from Annals of Internal Medicine). Ann Intern Med. 2009;151:264–70.
   PubMed Web of Science ®Google Scholar
• Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al.; for The WFN Research Group On ALS/MND. A revision of the El Escorial criteria – 2015. Amyotroph Lateral Scler Front Degener.2015;16:291–2.
   PubMed Web of Science ®Google Scholar
• Carvalho M. de, Dengler R, Eisen A, England JDD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
   PubMed Web of Science ®Google Scholar
• Staios M, Fisher F, Lindell AK, Ong B, Howe J, Reardon K. Exploring sarcasm detection in amyotrophic lateral sclerosis using ecologically valid measures. Front Hum Neurosci. 2013;7:178.
   PubMed Web of Science ®Google Scholar
• Branco LMT, de Rezende TJR, Roversi C de O, Zanao T, Casseb RF, de Campos BM, et al. Brain signature of mild stages of cognitive and behavioral impairment in amyotrophic lateral sclerosis. Psychiatry Res – Neuroimaging. 2018;272:58–64.
   PubMed Web of Science ®Google Scholar
• Keller J, Krimly A, Bauer L, Schulenburg S, Böhm S, Aho-özhan H, et al. A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS Screen. Amyotroph Lateral Scler Front Degener. 2017;18:443–50.
   PubMed Web of Science ®Google Scholar
• Poletti B, Solca F, Carelli L, Madotto F, Faini A, Monti A, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;8421:489–98.
   Web of Science ®Google Scholar
• Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:163–9.
   PubMed Web of Science ®Google Scholar
• Devenney EM, Landin-romero R, Irish M, Hornberger M, Mioshi E, Halliday GM, et al. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion. NeuroImage Clin. 2017;13:439–45.
   PubMed Web of Science ®Google Scholar
• Savage SA, Lillo P, Kumfor F, Kiernan MC, Hodges JR, Savage SA, et al. Emotion processing deficits distinguish pure amyotrophic lateral sclerosis from frontotemporal dementia. 2014;15:39–46.
   Google Scholar
• Leslie FVC, Hsieh S, Caga J, Savage SA, Hornberger M, Kiernan MC, et al. Semantic deficits in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2015;16: 46–53.
   PubMed Web of Science ®Google Scholar
• De Silva D, Hsieh S, Caga J, Leslie FVC, Kiernan MC, Hodges JR, et al. Motor function and behaviour across the ALS-FTD spectrum. Acta Neurol Scand. 2016;133:367–72.
   PubMed Web of Science ®Google Scholar
• Lillo P, Mioshi E, Burrell JR, Kiernan MC, Hodges JR, Hornberger M. Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One. 2012;7:e43993.
   PubMed Web of Science ®Google Scholar
• Trojsi F, Santangelo G, Caiazzo G, Siciliano M, Ferrantino T, Piccirillo G, et al. Neuropsychological assessment in different King’s clinical stages of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;8421:228–35.
   Google Scholar
• Keller J, Böhm S, Aho-özhan HEA, Loose M, Gorges M, Kassubek J, et al. Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis. Brain Imaging Behav. 2018;12:771–84.
   PubMed Web of Science ®Google Scholar
• Lulé D, Böhm S, Müller HP, Aho-Özhan H, Keller J, Gorges M, et al. Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex. 2018;101:163–71.
   PubMed Web of Science ®Google Scholar
• Iyer PM. Mismatch negativity as an indicator of cognitive sub-domain dysfunction in amyotrophic lateral sclerosis. Front Neurol. 2017;8:395.
   PubMed Web of Science ®Google Scholar
• Hübers A, Kassubek J, Georg G, Gorges M, Aho-Oezhan H, Keller J, et al. Pathological laughing and crying in amyotrophic lateral sclerosis is related to frontal cortex function. J Neurol. 2016;263:1788–95.
   PubMed Web of Science ®Google Scholar
• Nakamagoe K, Yamada S, Kawakami R, Miyake Z, Tozaka N, Okune S, et al. Vestibular dysfunction as cortical damage with amyotrophic lateral sclerosis. J Neurol Sci. 2019;397:4–8.
   PubMed Web of Science ®Google Scholar
• Sukockienė E, Allali G, Janssens J, Ferfoglia RI. Does executive functioning contribute to locomotion in amyotrophic lateral sclerosis patients? Amyotroph Lateral Scler Front Degener. 2019;20:123–5.
   PubMed Web of Science ®Google Scholar
• Cui B, Cui LY, Liu MS, Li XG, Ma JF, Fang J, et al. Behavioral symptoms in motor neuron disease and their negative impact on caregiver burden. Chin Med J. 2015;128:2295–300.
   PubMed Web of Science ®Google Scholar
• Barbagallo G, Nicoletti G, Cherubini A, Trotta M, Bono F, Valentino P, et al. Diffusion tensor MRI changes in gray structures of the frontal-subcortical circuits in amyotrophic lateral sclerosis. Neurol Sci. 2014;35:911–8.
   PubMed Web of Science ®Google Scholar
• Poletti B, Carelli L, Solca F, Lafronza A, Pedroli E, Faini A, et al. An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS. J Neurol. 2017;264:1136–45.
   PubMed Web of Science ®Google Scholar
• Poletti B, Carelli L, Faini A, Solca F, Meriggi P, Lafronza A, et al. The Arrows and Colors Cognitive Test (ACCT): a new verbal-motor free cognitive measure for executive functions in ALS. PLoS One. 2018;13:e0200953.
   PubMed Web of Science ®Google Scholar
• Pupillo E, The Eurals Consortium, Bianchi E, Messina P, Chiveri L, Lunetta C, Corbo M, et al. Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: a population based cross-sectional study. Amyotroph Lateral Scler Front Degener. 2015;16:324–30.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Wang Y, Doorish C, Lewis M, Mitsumoto H, Marder K, et al. A screening assessment of cognitive impairment in patients with ALS A screening assessment of cognitive impairment in patients with ALS. Amyotroph Lateral Scler. 2009;8:2968.
   Google Scholar
• Pilotto A, Rossi F, Rinaldi F, Compostella S, Cosseddu M, Borroni B, et al. Exploring olfactory function and its relation with behavioral and cognitive impairment in amyotrophic lateral sclerosis patients: a cross-sectional study. Neurodegener Dis. 2016;16:411–6.
   PubMed Web of Science ®Google Scholar
• Spinelli EG, Federica A, Ferraro P, Riva N, Lunetta C, Falzone YM, et al. Brain MR imaging in patients with lower motor neuron. Radiology. 2016;280:545–56.
   PubMed Web of Science ®Google Scholar
• Consonni M, Iannaccone S, Cerami C, Frasson P, Lacerenza M. The cognitive and behavioural pro fi le of amyotrophic lateral sclerosis: application of the consensus criteria. Behav Neurol. 2013;27:143–53.
   PubMed Web of Science ®Google Scholar
• Consonni M, Catrical E, Dalla Bella E, Gessa VCC, Lauria G, Cappa SFF. Beyond the consensus criteria: multiple cognitive profiles in amyotrophic lateral sclerosis? Cortex. 2016;81:162–7.
   PubMed Web of Science ®Google Scholar
• Cui B, Cui L, Liu M, Li X, Ma J, Fang J, et al. Neuropsychological investigation in Chinese patients with progressive muscular atrophy. PLoS One. 2015;10: e0128883.
   PubMed Web of Science ®Google Scholar
• Kasper E, Schuster C, Machts J, Kaufmann J. Microstructural white matter changes underlying cognitive and behavioural impairment in ALS – an in vivo study using DTI. PLoS One. 2014;9:e114543.
   PubMed Web of Science ®Google Scholar
• Wicks P, Abrahams S, Papps B, Shaw CE, Leigh PN, Goldstein LH. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol. 2009;256:234–41.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Williamson EH, Caga J, Matamala JM, Dharmadasa T, Howells J, et al. Primary lateral sclerosis and the amyotrophic lateral sclerosis – frontotemporal dementia spectrum. J Neurol. 2018;265:1819–28.
   PubMed Web of Science ®Google Scholar
• Schönecker S, Hell F, Bötzel K, Wlasich E, Ackl N, Süßmair C, et al.; German FTLD Consortium. The applause sign in frontotemporal lobar degeneration and related conditions. J Neurol. 2019;266:330–8.
   PubMed Web of Science ®Google Scholar
• Beeldman E, Raaphorst J, Twennaar MK, Govaarts R, Pijnenburg YAL, Haan RD, et al. The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2018;89:995–1002.
   PubMed Web of Science ®Google Scholar
• Marjanovíc IV, Selak-djokíc B, Períc S, Jankoviíc M, Arsenijevíc V, Basta I, et al. Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia. J Neurol. 2017;264:1091–8.
   PubMed Web of Science ®Google Scholar
• Heimrath J, Gorges M, Kassubek J, Müller H, Ludolph AC, Lulé D, et al. Additional resources and the default mode network: evidence of increased connectivity and decreased white matter integrity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:537–45.
   PubMed Web of Science ®Google Scholar
• Zimmerman EK, Eslinger PJ, Simmons Z, Barrett AM. Emotional perception deficits in amyotrophic lateral sclerosis. Cogn Behav Neurol. 2007;20:79–82.
   PubMed Web of Science ®Google Scholar
• Murphy J, Henry RGG, Langmore S, Kramer JHH, Miller BLL, Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64:530–4.
   PubMedGoogle Scholar
• Hervieu-Bègue M, Rouaud O, Graule Petot A, Catteau A, Giroud M. Semantic memory assessment in 15 patients with amyotrophic lateral sclerosis. Rev Neurol (Paris). 2016;2:307–12.
   Google Scholar
• Palmieri A, Sorarù G, Ascenzo CD, Balestreri S, Ermani M, Pegoraro E, et al. Specific numerical processing impairment in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:6–12.
   PubMed Web of Science ®Google Scholar
• Mantovan MC, Baggio L, Barba GD, Smith P, Pegoraro E, Soraru G. Memory deficits and retrieval processes in ALS 1. PLoS ONE. 2003;9:e114543.
   Google Scholar
• Hanagasi HA, Gurvit IH, Ermutlu N, Kaptanoglu G, Karamursel S, Idrisoglu HA, et al. Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials. Cogn Brain Res. 2002;14:234–44.
   PubMedGoogle Scholar
• Tomik B, Adamek D, Lechwacka A, Orłowiejska-Gillert M, Bała-Słodowska M, Głodzik-Sobańska L, et al. ALS-Plus syndrome. Pol J Pathol. 2000;51:191–6.
   PubMedGoogle Scholar
• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Fu X, Zhu W, Guo Z, Shu G, Cui F, Yang F, et al. 18F-fallypride PET-CT of dopamine D2/D3 receptors in patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2017;377:79–84.
   PubMed Web of Science ®Google Scholar
• Ohta Y, Sato K, Takemoto M, Takahashi Y, Morihara R, Nakano Y, et al. Behavioral and affective features of amyotrophic lateral sclerosis patients. J Neurol Sci. 2017;381:119–25.
   PubMed Web of Science ®Google Scholar
• Gillingham SMM, Yunusova Y, Ganda A, Rogaeva E, Black SEE, Stuss DTT, et al. Assessing cognitive functioning in ALS: a focus on frontal lobe processes. Amyotroph Lateral Scler Front Degener. 2017;18:182–92.
   PubMed Web of Science ®Google Scholar
• Benbrika S, Doidy F, Carluer L, Mondou A, Buhour M, Eustache F, et al. Alexithymia in amyotrophic lateral sclerosis and its neural correlates. Front Neurol. 2018;9:566.
   PubMed Web of Science ®Google Scholar
• Ferraro PM, Jester C, Olm CA, Placek K, Agosta F, Elman L, et al. Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies. Neurobiol Aging. 2018;68:85–92.
   PubMed Web of Science ®Google Scholar
• Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriat Psychiatry. 2006;21:1078–85.
   PubMed Web of Science ®Google Scholar
• Hu WT, Shelnutt M, Wilson A, Yarab N, Kelly C, Grossman M, et al. Behavior matters-cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One. 2013;8: e57584.
   PubMed Web of Science ®Google Scholar
• Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBSTM). Amyotroph Lateral Scler. 2010;11:303–11.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Front Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB A frontal assessment battery at bedside. Neurology. 2000;55:1621–6.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
   PubMed Web of Science ®Google Scholar
• Flaherty-Craig C, Brothers A, Dearman B, Eslinger P, Simmons Z. Penn State screen exam for the detection of frontal and temporal dysfunction syndromes: application to ALS. Amyotroph Lateral Scler. 2009;10:107–12.
   PubMed Web of Science ®Google Scholar
• Murphy J, Ahmed F, Lomen-Hoerth C, Murphy J, Ahmed F, Lomen-Hoerth C. The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS. Amyotroph Lateral Scler Front Degener. 2015;16:24–30.
   PubMed Web of Science ®Google Scholar
• Libon DJ, Rascovsky K, Gross RG, White MT, Xie SX, Dreyfuss M, et al. Validated screening measure for dementia. Clin Neuropsychol. 2011;25:1314–30.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, Beeldman E, Schmand BA, Berkhout J, Linssen W, Berg Van Den LH, et al. The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS. Neurology 2012; 79:1377–83.
   PubMed Web of Science ®Google Scholar
• Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 1991;38:143–62.
   PubMed Web of Science ®Google Scholar
• Elamin M, Pinto-grau M, Burke TOM, Bede P, Rooney J, Sullivan MO, et al. Identifying behavioural changes in ALS: validation of the Beaumont Behavioural Inventory (BBI). Amyotroph Lateral Scler Front Degener. 2017;18:68–73.
   PubMed Web of Science ®Google Scholar
• Radakovic R, Abrahams S. Developing a new apathy measurement scale: dimensional apathy scale. Psychiatry Res. 2014;219:658–63.
   PubMed Web of Science ®Google Scholar
• Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementi. Can J Neurol Sci. 1997;24:29–36.
   PubMed Web of Science ®Google Scholar
• Grace J, Malloy P. Frontal Systems Behavioural Scale (FrSBe): Professional Manual. Lutz, FL: Psychological Assessment Resources; 2001.
   Google Scholar
• Mioshi E, Hsieh S, Caga J, Ramsey E, Chen K, Lillo P, et al. A novel tool to detect behavioural symptoms in ALS. Amyotroph Lateral Scler Front Degener. 2014;15:298–304.
   PubMed Web of Science ®Google Scholar
• Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–14.
   PubMed Web of Science ®Google Scholar
• Wedderburn C, Wear H, Brown J, Mason SJ, Barker RA, Hodges J, et al. The utility of the Cambridge Behavioural Inventory in neurodegenerative disease. J Neurol Neurosurg Psychiatry. 2008;79:500–3.
   PubMed Web of Science ®Google Scholar
• Barrash J, Anderson SW, Hathaway-Nepple J, Jones RD, Tranel D, et al. The Iowa Scales of Personality Change. Iowa City: University of Iowa College of Medicine, Department of Neurology; 1997.
   Google Scholar
• Santangelo G, Siciliano M, Trojano L, Femiano C, Monsurrò R, Tedeschi G, et al. Apathy in amyotrophic lateral sclerosis: insights from Dimensional Apathy Scale. Amyotroph Lateral Scler Front Degener. 2017; 18:434–42.
   PubMed Web of Science ®Google Scholar
• Turon-Sans J, Gascon-Bayarri J, Reñé R, Rico I, Paipa A, Povedano M, et al. Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test. Amyotroph Lateral Scler Front Degener. 2016;17:221–7.
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:E1370–80.
   PubMed Web of Science ®Google Scholar
• Trojsi F, Santangelo G, Caiazzo G, Siciliano M, Ferrantino T, Piccirillo G, et al. Neuropsychological assessment in different King’s clinical stages of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2016;17:228–35.
   PubMed Web of Science ®Google Scholar
• Balendra R, Jones A, Jivraj N, Steen IN, Young CA, Shaw PJ, et al.; UK-MND LiCALS Study Group; Mito Target ALS Study Group. Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. J Neurol Neurosurg Psychiatry. 2015;86:45–9.
   PubMed Web of Science ®Google Scholar
• Burkhardt C, Neuwirth C, Weber M. Longitudinal assessment of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): lack of practice effect in ALS patients?. Amyotroph Lateral Scler Front Degener. 2017;18:202–9.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, Visser d. M, Tol v. M-J, Linssen W, Kooi, Van, der AJ, Haan d. R, et al. Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy. J Neurol Neurosurg Psychiatry. 2011;82:170–5.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Beeldman E, Raaphorst J, Izumi Y, Yoshino H, Masuda M, et al. Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J). J Neurol Sci. 2016;367:51–5.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, Beeldman E, Jaeger B, Schmand BA, Van Den Berg LH, Weikamp JG, et al. Is the frontal assessment battery reliable in ALS patients? Amyotroph Lateral Scler Front Degener. 2013;14:73–4.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, Beeldman E, Schmand BA, Van Den Berg LH, De Visser M, De Haan RJ. Response to ‘Exploring limits of neuropsychological screening in ALS: The FAB problem.’ Amyotroph Lateral Scler Front Degener. 2013;14:159–60.
   PubMed Web of Science ®Google Scholar
• Tremolizzo L, Ferrarese C, Appollonio I. Exploring limits of neuropsychological screening in ALS: the FAB problem. Amyotroph Lateral Scler Front Degener. 2013;14:157–8.
   PubMed Web of Science ®Google Scholar
• Wei Q, Chen X, Zheng Z, Huang R, Guo X, Cao B, et al. Screening for cognitive impairment in a Chinese ALS population. Amyotroph Lateral Scler Front Degener. 2015;16:40–5.
   PubMed Web of Science ®Google Scholar
• Xu Z, Alruwaili ARS, Henderson RD, McCombe PA. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: frequency of abnormality and effect on survival. J Neurol Sci. 2017;376:16–23.
   PubMed Web of Science ®Google Scholar
• Lillo P, Savage S, Mioshi E, Kiernan MC, Hodges JR. Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler. 2012;13:102–9.
   PubMed Web of Science ®Google Scholar
• Branco LMT, Zanao T, Rezende TD, Casseb RF, Balthazar MF, Woolley SC, et al. Transcultural validation of the ALS-CBS Cognitive Section for the Brazilian population. Amyotroph Lateral Scler Front Degener. 2017;18:60–7.
   PubMed Web of Science ®Google Scholar
• Rabkin J, Goetz R, Murphy J, Factor-Litvak P, Mitsumoto H. Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort. Neurology 2016;87:1320–8.
   PubMed Web of Science ®Google Scholar
• Ye S, Rosenbohm A, Böhm S, Uttner I, Ji Y, Albert C, et al. Cognitive and behavioral impairments in German and Chinese ALS populations – a post-hoc comparison of national study data. Amyotroph Lateral Scler Front Degener. 2019;20:28–36.
   PubMed Web of Science ®Google Scholar
• Bakker LA, Schröder CD, Spreij LA, Verhaegen M, De Vocht J, Van Damme P, et al. Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen. Amyotroph Lateral Scler Front Degener. 2019;20:19–27.
   PubMed Web of Science ®Google Scholar
• Gorges M, Müller HP, Lulé D, Tredici KD, Del Tredici K, Brettschneider J, et al. Eye movement deficits are consistent with a staging model of pTDP-43 pathology in amyotrophic lateral sclerosis. PLoS One. 2015;10:e0142546.
   PubMed Web of Science ®Google Scholar
• Lulé D, Burkhardt C, Abdulla S, Böhm S, Kollewe K, Uttner I, et al. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Front Degener. 2015;16:16–23.
   PubMed Web of Science ®Google Scholar
• Mora JS, Salas T, Fernández MC, Rodríguez V, Marín S, Chaverri D, et al. Spanish adaptation of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen. Amyotroph Lateral Scler Front Degener 2018;19:74–9.
   PubMed Web of Science ®Google Scholar
• Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Front Degener. 2015;16:172–9.
   PubMed Web of Science ®Google Scholar
• Poletti B, Solca F, Carelli L, Faini A, Lafronza A, Monti A, et al. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotroph Lateral Scler Front Degener. 2018;19:387–95.
   PubMed Web of Science ®Google Scholar
• Ye S, Ji Y, Li C, He J, Liu X, Fan D. The Edinburgh cognitive and behavioural ALS screen in a Chinese amyotrophic lateral sclerosis population. PLoS One. 2016;11:e0155496.
   PubMed Web of Science ®Google Scholar
• Yoshizawa K, Yasuda N, Fukuda M, Yukimoto Y, Ogino M, Hata W, et al. Syntactic comprehension in patients with amyotrophic lateral sclerosis. Behav Neurol. 2014;2014. Article ID 230578.
   PubMed Web of Science ®Google Scholar
• Barulli MR, Fontana A, Panza F, Copetti M, Bruno S, Tursi M, et al. Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study. BMJ Open. 2015;5:e007069.
   PubMed Web of Science ®Google Scholar
• Ahn S, Kim S-H, Kim J, Kim S-M, Kim SH, Sung J-J, et al. Frontal assessment battery to evaluate frontal lobe dysfunction in ALS patients. Can J Neurol Sci. 2011;38:242–6.
   PubMed Web of Science ®Google Scholar
• Floris G, Borghero G, Chi A, Secchi L, Cannas A, Sardu C, et al. Cognitive screening in patients with amyotrophic lateral sclerosis in early stages. Amyotroph Lateral Scler. 2012;13:95–101.
   PubMed Web of Science ®Google Scholar
• Osborne RA, Sekhon R, Johnston W, Kalra S. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2014;336:191–6.
   PubMed Web of Science ®Google Scholar
• Oskarsson B, Quan D, Rollins YD, Neville HE, Ringel SP, Arciniegas DB. Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: a preliminary experience. Amyotroph Lateral Scler. 2010;11:244–7.
   PubMed Web of Science ®Google Scholar
• Terada T, Miyata J, Obi T, Kubota M, Yoshizumi M, Yamazaki K, et al. Frontal assessment battery and frontal atrophy in amyotrophic lateral sclerosis. Brain Behav. 2017;7:e00707.
   PubMed Web of Science ®Google Scholar
• Ji Y, Wei L, Chui D, Wang K, Fan D. Prospective memory tasks: a more sensitive method for screening cognitive impairment in early-phase amyotrophic lateral sclerosis? BMC Neurol. 2012;12:142.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Tanaka H, Hirata K. Clinical neurophysiology cognitive deficits in amyotrophic lateral sclerosis evaluated by event-related potentials. Clin Neurophysiol. 2009;120:659–64.
   PubMed Web of Science ®Google Scholar
• Stojkovic T, Stefanova E, Pekmezovic T, Peric S, Stevic Z. Executive dysfunction and survival in patients with amyotrophic lateral sclerosis: preliminary report from a Serbian centre for motor neuron disease. Amyotroph Lateral Scler Front Degener. 2016;17:543–7.
   PubMed Web of Science ®Google Scholar
• Zhu W, Fu X, Cui F, Yang F, Ren Y, Zhang X, et al. ALFF value in right parahippocampal gyrus acts as a potential marker monitoring amyotrophic lateral sclerosis progression: a neuropsychological, voxel-based morphometry, and resting-state functional MRI study. J Mol Neurosci. 2015;57:106–13.
   PubMed Web of Science ®Google Scholar
• Tremolizzo L, Pellegrini A, Conti E, Arosio A, Gerardi F, Lunetta C, et al. BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis. Neurodegener Dis. 2016;16:192–8.
   PubMed Web of Science ®Google Scholar
• Flaherty-Craig C, Brothers A, McFalls A, Yang C, Simmons Z. VALUES: a national multicenter study of regional and gender differences in frontotemporal disease in amyotrophic lateral sclerosis. Neurodegener Dis Manag. 2012;2:325–36.
   Google Scholar
• Pinto-grau M, Burke T, Lonergan K, Mchugh C, Mays I, Madden C, et al. Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data. Amyotroph Lateral Scler Front Degener. 2017;18:99–106.
   PubMed Web of Science ®Google Scholar
• Radakovic R, Stephenson L, Colville S, Swingler R, Chandran S, Abrahams S. Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale. J Neurol Neurosurg Psychiatry. 2016;87:663–9.
   PubMed Web of Science ®Google Scholar
• Chiò A, Vignola A, Mastro E, Giudici AD, Iazzolino B, Calvo A, et al. Neurobehavioral symptoms in ALS are negatively related to caregivers’ burden and quality of life. Eur J Neurol. 2010;17:1298–303.
   PubMed Web of Science ®Google Scholar
• Van der Hulst EJ, Bak TH, Abrahams S. Impaired affective and cognitive theory of mind and behavioural change in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:1208–15.
   PubMed Web of Science ®Google Scholar
• Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, et al. Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol. 2010;17:103–10.
   PubMed Web of Science ®Google Scholar
• Pinto-Grau M, Costello E, O’Connor S, Elamin M, Burke T, Heverin M, et al. Assessing behavioural changes in ALS: cross-validation of ALS-specific measures. J Neurol. 2017;264:1397–401.
   PubMed Web of Science ®Google Scholar
• Wei Q, Chen XP, Zheng ZZ, Huang R, Guo XY, Cao B, et al. Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China. J Neurol. 2014;261:2393–400.
   PubMed Web of Science ®Google Scholar
• Oh SI, Park A, Kim H, Oh K, Choi H, Kwon M, et al. Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations. PLoS One. 2014;9:e87163.
   PubMed Web of Science ®Google Scholar
• Wei Q, Chen X, Cao B, Ou R, Zhao B, Wu Y, et al. Associations between neuropsychiatric symptoms and cognition in Chinese patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2016;17:358–65.
   PubMed Web of Science ®Google Scholar
• Glenn, M. B., Burke, D. T., O'Neil-Pirozzi, T., Goldstein, R., Jacob, L., & Kettell, J. (2002). Cutoff score on the apathy evaluation scale in subjects with traumatic brain injury. Brain Injury, 16(6), 509–516. https://doi.org/10.1080/02699050110119132
   Google Scholar